title: [Raynaud's phenomenon secondary to nebivolol].
authors.affiliation: Servicio de Cardiología, Hospital General Universitario de Elche, Elche, Alicante, España.
authors.forename: Nuria
authors.initials: N
authors.lastname: V-Ibarra
authors.affiliation: Servicio de Cardiología, Hospital General Universitario de Elche, Elche, Alicante, España.
authors.forename: Gregorio
authors.initials: G
authors.lastname: de Lara
authors.affiliation: Servicio de Cardiología, Hospital General Universitario de Elche, Elche, Alicante, España.
authors.forename: Vicente
authors.initials: V
authors.lastname: Pernias
authors.affiliation: Servicio de Cardiología, Hospital General Universitario de Elche, Elche, Alicante, España.
authors.forename: Laura
authors.initials: L
authors.lastname: Nuñez
authors.affiliation: Servicio de Cardiología, Hospital General Universitario de Elche, Elche, Alicante, España.
authors.forename: Fernando
authors.initials: F
authors.lastname: García de Burgos
authors.affiliation: Servicio de Cardiología, Hospital General Universitario de Elche, Elche, Alicante, España. Electronic address: pedromorillas68@gmail.com.
authors.forename: Pedro
authors.initials: P
authors.lastname: Morillas
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D000068577:Nebivolol / Q000009:adverse effects*; D011928:Raynaud Disease / Q000139:chemically induced*
chemical_list: D000959:Antihypertensive Agents; D000068577:Nebivolol